BlackRock
NUVB icon

BlackRock’s Nuvation Bio NUVB Stock Holding History

BlackRock’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157M Buy
27,630,837
+2,530,463
+10% +$12.4M ﹤0.01% 1946
2026
Q1 		$108M Buy
25,100,374
+430,598
+2% +$2.4M ﹤0.01% 2061
2025
Q4 		$221M Buy
24,669,776
+65,617
+0.3% +$406K ﹤0.01% 1614
2025
Q3 		$91M Sell
24,604,159
-1,128,831
-4% -$3.08M ﹤0.01% 2158
2025
Q2 		$50.2M Buy
25,732,990
+7,254,203
+39% +$15.1M ﹤0.01% 2447
2025
Q1 		$32.5M Sell
18,478,787
-62,993
-0.3% -$143K ﹤0.01% 2632
2024
Q4 		$49.3M Buy
18,541,780
+1,567,783
+9% +$4.04M ﹤0.01% 2462
2024
Q3 		$38.9M Buy
16,973,997
+737,233
+5% +$2.25M ﹤0.01% 2633
2024
Q2 		$47.4M Buy
16,236,764
+3,707,716
+30% +$11.3M ﹤0.01% 2441
2024
Q1 		$45.6M Sell
12,529,048
-353,381
-3% -$679K ﹤0.01% 2487
2023
Q4 		$19.5M Sell
12,882,429
-325,220
-2% -$419K ﹤0.01% 3025
2023
Q3 		$17.7M Sell
13,207,649
-219,725
-2% -$366K ﹤0.01% 3004
2023
Q2 		$24.2M Buy
13,427,374
+2,229,603
+20% +$3.79M ﹤0.01% 2915
2023
Q1 		$18.6M Buy
11,197,771
+201,036
+2% +$407K ﹤0.01% 3015
2022
Q4 		$21.1M Buy
10,996,735
+709,843
+7% +$1.44M ﹤0.01% 3011
2022
Q3 		$23M Buy
10,286,892
+155,647
+2% +$444K ﹤0.01% 2957
2022
Q2 		$32.8M Sell
10,131,245
-1,120,810
-10% -$4.89M ﹤0.01% 2782
2022
Q1 		$59.2M Buy
11,252,055
+455,021
+4% +$2.56M ﹤0.01% 2483
2021
Q4 		$91.8M Buy
10,797,034
+5,397,329
+100% +$49.6M ﹤0.01% 2266
2021
Q3 		$53.7M Buy
5,399,705
+2,186,242
+68% +$19.8M ﹤0.01% 2616
2021
Q2 		$29.9M Buy
3,213,463
+1,773,029
+123% +$20.2M ﹤0.01% 3055
2021
Q1 		$15.1M Buy
1,440,434
+740,434
+106% +$8.28M ﹤0.01% 3342
2020
Q4 		$8.19M Buy
+700,000
New +$7.28M ﹤0.01% 3474

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock's NUVB Position: Q2 2026 in Review

BlackRock increased its Nuvation Bio (NUVB) stake by 10% in Q2 2026, buying an estimated $12.4M and bringing the position to 27,630,837 shares worth $157M. The position accounts for ﹤0.01% of the portfolio, ranked #1946.

BlackRock first reported a position in NUVB in Q4 2020 and has held it in 23 quarters since. The position peaked at $221M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • BlackRock held 27,630,837 shares of Nuvation Bio worth $157M as of Q2 2026.
  • BlackRock bought 2,530,463 Nuvation Bio shares in Q2 2026, an estimated $12.4M.
  • Nuvation Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1946 holding.
  • BlackRock first reported a position in Nuvation Bio in Q4 2020 and has held it in 23 quarters since.
  • BlackRock's Nuvation Bio position peaked at $221M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.